New Anti-cancer Agents: Design, Synthesis and Applications
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 67
Special Issue Editor
Special Issue Information
Dear Colleagues,
To date, 317 anticancer drugs have been licensed, with 286 approved by the FDA, and 212 approved by the EMA. These drugs can be classified according to their mechanism of action, indication, or chemical structure. Most chemotherapeutic agents cause side effects, which limit their use. Consequently, there is a growing need for research focused on designing novel targeted drugs. This Special Issue of IJMS is devoted to all stages of the process of developing new drugs, including design, synthesis, and pharmacological evaluation of anti-cancer activity in novel therapeutics. Submissions of both research and review articles are welcome for this Special Issue.
This Special Issue is supervised by Dr. Robert Czarnomysy and assisted by our Topical Advisory Panel Member Dr. Anna Szymanowska ([email protected]; Department of Biotechnology, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland).
Dr. Robert Czarnomysy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-cancer drugs
- cancer drug development
- cancer therapy
- rational drug design
- structure–activity relationship
- cancer therapeutics
- cytotoxicity
- apoptosis
- anti-tumor activity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
